FOLH1 and neoplasm: For example, prostate-specific membrane antigen (PSMA)-targeted CAR-T cells have demonstrated enhanced efficacy when combined with metabolic inhibitors such as dichloroacetate (DCA), which shifts tumor metabolism from glycolysis to oxidative phosphorylation, thereby reducing lactate accumulation and improving T cell functionality 102.